Although several reviews on PCSK9 inhibitors derived from natural products have been reported, they typically focused on specific disorders, such as atherosclerosis [37], hypercholesterolemia [36], and cardiovascular diseases [16,38,39], or reviewed the mechanisms associated with these diseases [16,36,40]. This evidence concerns the gene PCSK9 and Hypercholesterolemia.